Eli Lilly Enters a ~$1.4B Licensing Agreement with Sangamo Therapeutics for its STAC-BBB Capsid
Shots: Sangamo has granted Eli Lilly global exclusive license of STAC-BBB for one...
Shots: Sangamo has granted Eli Lilly global exclusive license of STAC-BBB for one...
Shots: Sanofi has licensed an undisclosed Nurix program targeting a previously und...
Shots: Ono Pharmaceutical entered into an option agreement to obtain exclusive rig...
Shots: Lexicon has granted Novo Nordisk exclusive global rights to develop, manufa...
Shots: Ionis has granted Sobi global exclusive rights of olezarsen excl. the US, C...
Shots: Bayer & Suzhou Puhe BioPharma have entered into a global license agreem...
Incisive News in 3 Shots.
Modal body text goes here.